Evaluation of Pigmented Skin Lesions With MelaFind(R) System

Completed · Phase 3

Conditions studied: Melanoma

In brief

The purpose of this clinical trial is to demonstrate that MelaFind®, a new instrument that uses machine vision for non-invasive early detection of cutaneous pigmented malignant melanoma, is safe and effective. MelaFind® acquires digital images of the lesion with illumination in different spectral bands, from visible to near infrared, and automatically analyzes these images. Diagnostic accuracy of MelaFind® and that of study dermatologists will be evaluated. The reference standard will be final interpretation of lesions by central dermatohistopathology.

Key facts

Study ID
NCT00434057
Run by
MELA Sciences, Inc.
People needed
1383
Starts
2007-01-01
Expected to finish
2008-07-01
Last updated by the study team
2012-02-14

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.